Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
17 authors.
Ho Yan YeungDepartment of Biomedical Sciences, University of Copenhagen, Blegdamsvej 3, DK-2200, Copenhagen N, Denmark.ORCID 0000-0003-3087-238X
Iris Bea L RamiroDepartment of Biomedical Sciences, University of Copenhagen, Blegdamsvej 3, DK-2200, Copenhagen N, Denmark.ORCID 0000-0003-3971-3107
Daniel B AndersenDepartment of Biomedical Sciences, University of Copenhagen, Blegdamsvej 3, DK-2200, Copenhagen N, Denmark.
Thomas Lund KochDepartment of Biomedical Sciences, University of Copenhagen, Blegdamsvej 3, DK-2200, Copenhagen N, Denmark.
Alexander HamiltonDepartment of Biology, University of Copenhagen, Ole Maaløes Vej 5, DK-2200, Copenhagen N, Denmark.
Walden E Bjørn-YoshimotoDepartment of Biomedical Sciences, University of Copenhagen, Blegdamsvej 3, DK-2200, Copenhagen N, Denmark.ORCID 0000-0003-1019-9239
Samuel EspinoSchool of Biological Sciences, University of Utah, 257 South 1400 East, Salt Lake City, UT, 84112, USA.
Sergey Y VakhrushevCopenhagen Center for Glycomics, Department of Cellular and Molecular Medicine, University of Copenhagen, Blegdamsvej 3, DK-2200, Copenhagen N, Denmark.ORCID 0000-0002-0418-5765
Kasper B PedersenCopenhagen Center for Glycomics, Department of Cellular and Molecular Medicine, University of Copenhagen, Blegdamsvej 3, DK-2200, Copenhagen N, Denmark.
Noortje de HaanLeiden University Medical Center, Center for Proteomics and Metabolomics, 2333, ZA, Leiden, The Netherlands.ORCID 0000-0001-7026-6750
Agnes L Hipgrave EderveenLeiden University Medical Center, Center for Proteomics and Metabolomics, 2333, ZA, Leiden, The Netherlands.ORCID 0000-0003-1689-0442
Baldomero M OliveraSchool of Biological Sciences, University of Utah, 257 South 1400 East, Salt Lake City, UT, 84112, USA.
Jakob G KnudsenDepartment of Biology, University of Copenhagen, Ole Maaløes Vej 5, DK-2200, Copenhagen N, Denmark.ORCID 0000-0001-7237-8457
Hans Bräuner-OsborneDepartment of Drug Design and Pharmacology, University of Copenhagen, Jagtvej 160, DK-2100, Copenhagen, Denmark.ORCID 0000-0001-9495-7388
Katrine T SchjoldagerCopenhagen Center for Glycomics, Department of Cellular and Molecular Medicine, University of Copenhagen, Blegdamsvej 3, DK-2200, Copenhagen N, Denmark.ORCID 0000-0002-8592-6763
Jens Juul HolstDepartment of Biomedical Sciences, University of Copenhagen, Blegdamsvej 3, DK-2200, Copenhagen N, Denmark.ORCID 0000-0001-6853-3805
Helena Safavi-HemamiDepartment of Biomedical Sciences, University of Copenhagen, Blegdamsvej 3, DK-2200, Copenhagen N, Denmark. helena.safavi@utah.edu.ORCID 0000-0002-1984-2721
Funding
“Conus venom peptides and their molecular targets: Using pharmaconomics and neuroethology as a framework for discovery”R01GM144719 · NIGMS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · 2022 to 2025
$1.1M
Carlsbergfondet (Carlsberg Foundation) CF20-0248NIGMS NIH HHS R01 GM144719Novo Nordisk Fonden (Novo Nordisk Foundation) 0054300U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) GM144719
6 · The paper itself
Abstract
Venomous animals have evolved diverse molecular mechanisms to incapacitate prey and defend against predators. Most venom components disrupt nervous, locomotor, and cardiovascular systems or cause tissue damage. The discovery that certain fish-hunting cone snails use weaponized insulins to induce hypoglycemic shock in prey highlights a unique example of toxins targeting glucose homeostasis. Here, we show that, in addition to insulins, the deadly fish hunter, Conus geographus, uses a selective somatostatin receptor 2 (SSTR
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
Fish-hunting cone snail disrupts prey's glucose homeostasis with weaponized mimetics of somatostatin and insulin. · full record | Socratic